Economic analyses, including the cost of introducing and delivering RTS,S, form a critical piece of the puzzle to inform countries’ decision-making around use of the vaccine.
PATH-conducted studies in Ghana, Kenya, and Malawi have generated incremental cost estimates of RTS,S introduction and delivery from the government’s perspective, using data on actual activities and costs incurred for pilot introduction of the vaccine.
Each country’s study included operational cost data collected from representative health facilities within malaria vaccinating areas as well as from regional and national levels. Data were gathered on malaria vaccine planning and coordination activities, vaccine procurement and distribution, as well as training, sensitization, social mobilization, service delivery, supervision, and monitoring activities.
PATH is also conducting budget impact analyses to help countries estimate the financial and economic impact of RTS,S introduction on national and health program budgets.
The studies show that the resources needed to deliver RTS,S may be generally comparable with other new vaccines. The information gathered should help national and global decision-makers assess the economic feasibility of delivering RTS,S and help inform decision-making and planning around further use of the vaccine.